A Major Milestone for L&P® Sucralose: Officially Approved with Class A Pharmaceutical Excipient Status

In April 2026, the National Medical Products Administration (NMPA) officially announced the results of the pharmaceutical excipient-associated review and approval. The review status of Sucralose (pharmaceutical excipient) produced by L&P Food Ingredient Co., Ltd. was successfully upgraded from Status I to Status A.

L&P Foods has now become the first company in Guangdong Province to obtain Class A status qualification for pharmaceutical-grade sucralose excipient. The product can now be directly used in the production of marketed pharmaceutical formulations, officially positioning the company among the leading domestic suppliers of pharmaceutical-grade sweeteners and further supporting the high-quality development of China’s high-end pharmaceutical excipient industry.

Source: Center for Drug Evaluation (CDE), National Medical Products Administration (NMPA), China

Advancing Compliance with Recognized Pharmaceutical Standards

As a high-threshold pharmaceutical excipient, pharmaceutical-grade sucralose must undergo stringent registration and associated review procedures for APIs, excipients, and packaging materials regulated by NMPA. The successful upgrade to Status A represents official recognition of L&P Foods product quality and manufacturing system, while also laying a solid foundation for broader applications across pharmaceutical, medical nutrition, and functional food industries.

  Product Name: Sucralose (Pharmaceutical Excipient)

  Registration Number: F20190000634

  Review Status: Successfully upgraded from Status I to Status A

  (Status A indicates approval for use in marketed pharmaceutical formulations, while Status I indicates materials that have not yet completed associated review and approval with finished drug products.)

  Applications: Marketed pharmaceutical products, Foods for Special Medical Purposes (FSMP), premium dietary supplements, and functional foods

  Manufacturing Standards: Produced in GMP-compliant cleanroom facilities with fully controlled and traceable quality management processes, in strict accordance with pharmacopeial standards

The achievement of Class A status marks a significant milestone for L&P Foods in expanding into the high-end pharmaceutical excipient sector, while also creating new opportunities to strengthen the company’s multi-sector presence and core competitiveness.

Looking ahead, L&P Foods will continue to leverage its compliant production capacity, stringent quality standards, and diversified product portfolio to provide cost-effective and highly stable taste-masking solutions for pharmaceutical companies. At the same time, the company aims to support the development of broader health-related industries, including Foods for Special Medical Purposes (FSMP) and functional foods, helping reduce reliance on imports and promoting the advancement of China’s high-end ingredient industry. Together with industry partners, L&P Foods remains committed to contributing to the high-quality development of the global health and wellness industry.